Inventurus Knowledge Solutions (IKS) shares, which made debut on the exchanges today (Thursday, December 19), saw block deals where Norway-based Norges Bank bought over 34 lakh shares worth Rs 652 crore.Norges Bank bought shares via Norges Bank on Account of The Government Pension Fund Global in two tranches of 16.59 lakh and 17.50 lakh shares at a price of Rs 1,923.92 apiece and Rs 1,899.67 per share, respectively.IKS stock was listed at Rs 1,900 on the bourses — a 43% premium over the issue price of Rs 1,329.Its shares on Thursday ended at Rs 2,030 on the NSE, gaining by Rs 130 or 6.84% over the listing price.Also Read: Year-ender 2024: Zaggle, Oracle and 5 other SMIDs rule IT sector in CY24 with up to 150% returns. How about 2025?The IPO of Inventurus received a strong response from investors with an overall subscription of 53 times at close. The Rs 2,498 crore IPO is completely an offer for sale (OFS) of up to 1.87 crore equity shares. Since the IPO is entirely an OFS, the proceeds from the offer will go to the selling shareholders.Based on annualised FY24 earnings, and fully diluted post-IPO paid-up capital, the company asked for a PE of 54.66x, which seems fully priced in looking at the company’s financial growth trajectory.Founded in 2006, Inventurus Knowledge Solutions offers critical support services to healthcare companies, specialising in areas such as administrative tasks, clinical support, medical documentation management, and virtual medical scribing.The company’s technology-driven solutions aim to streamline healthcare operations, enhance efficiency, and alleviate administrative burdens, ensuring that healthcare providers can focus more on delivering quality patient care.As of September 2024, the company has over 778 healthcare organisations as their clients, including health systems, academic medical centres, multi-specialty medical groups, single-specialty medical groups, ancillary healthcare organisations and other outpatient and inpatient healthcare delivery organisations.Some of the key clients include Mass General Brigham Inc, Texas Health Care PLLC, and The GI Alliance Management.For the six months ended September 2024, its revenue from operations doubled to Rs 1,283 crore, while profit in the same period rose marginally to Rs 208 crore.(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)